Kevin Kotler

Kevin Kotler, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Biodelivery Sciences International Inc, Avadel Pharmaceuticals PLC and QLT Inc/BC. The record holds 14 filings, for trades running from 29 November 2016 to 22 March 2022.

On the market, this insider has only ever bought: 4 purchases, €1.7M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants and 6 option exercises.

The median purchase comes to €335k. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 22 March 2022, the filings show a transaction in Biodelivery Sciences International Inc. The latest purchase dates back some time: it was published 1,794 days ago, on 22 November 2021. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.